HEADER TRANSFERASE 04-FEB-18 6FNJ TITLE CRYSTAL STRUCTURE OF EPHRIN B4 (EPHB4) RECEPTOR PROTEIN KINASE WITH AN TITLE 2 ISOMER OF NVP-BHG712 COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPHRIN TYPE-B RECEPTOR 4; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HEPATOMA TRANSMEMBRANE KINASE,TYROSINE-PROTEIN KINASE COMPND 5 TYRO11; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EPHB4, HTK, MYK1, TYRO11; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS INHIBITOR, COMPLEX, PROTEIN TYROSINE KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.KUDLINZKI,A.TROESTER,K.WITT,V.L.LINHARD,K.SAXENA,H.SCHWALBE REVDAT 3 17-JAN-24 6FNJ 1 REMARK REVDAT 2 29-AUG-18 6FNJ 1 JRNL REVDAT 1 08-AUG-18 6FNJ 0 JRNL AUTH A.TROSTER,S.HEINZLMEIR,B.T.BERGER,S.L.GANDE,K.SAXENA, JRNL AUTH 2 S.SREERAMULU,V.LINHARD,A.H.NASIRI,M.BOLTE,S.MULLER,B.KUSTER, JRNL AUTH 3 G.MEDARD,D.KUDLINZKI,H.SCHWALBE JRNL TITL NVP-BHG712: EFFECTS OF REGIOISOMERS ON THE AFFINITY AND JRNL TITL 2 SELECTIVITY TOWARD THE EPHRIN FAMILY. JRNL REF CHEMMEDCHEM V. 13 1629 2018 JRNL REFN ESSN 1860-7187 JRNL PMID 29928781 JRNL DOI 10.1002/CMDC.201800398 REMARK 2 REMARK 2 RESOLUTION. 1.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.34 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.320 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 204142 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.050 REMARK 3 FREE R VALUE TEST SET COUNT : 2143 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.3665 - 3.0562 1.00 14091 150 0.1531 0.1609 REMARK 3 2 3.0562 - 2.4258 1.00 14018 149 0.1869 0.2040 REMARK 3 3 2.4258 - 2.1192 1.00 13920 148 0.1832 0.2073 REMARK 3 4 2.1192 - 1.9254 1.00 13901 148 0.1984 0.2536 REMARK 3 5 1.9254 - 1.7874 1.00 13888 146 0.2016 0.2431 REMARK 3 6 1.7874 - 1.6820 1.00 13850 148 0.2282 0.2364 REMARK 3 7 1.6820 - 1.5978 1.00 13843 147 0.2748 0.3423 REMARK 3 8 1.5978 - 1.5282 0.99 13802 147 0.3427 0.3710 REMARK 3 9 1.5282 - 1.4694 1.00 13854 147 0.3881 0.3939 REMARK 3 10 1.4694 - 1.4187 1.00 13833 148 0.4400 0.4337 REMARK 3 11 1.4187 - 1.3743 1.00 13786 146 0.5111 0.4716 REMARK 3 12 1.3743 - 1.3350 1.00 13827 147 0.5832 0.6001 REMARK 3 13 1.3350 - 1.2999 0.96 13336 142 0.6525 0.7725 REMARK 3 14 1.2999 - 1.2682 0.86 11913 127 0.7097 0.6554 REMARK 3 15 1.2682 - 1.2393 0.73 10136 103 0.7323 0.6527 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 43.180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.44 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4501 REMARK 3 ANGLE : 0.983 6112 REMARK 3 CHIRALITY : 0.182 654 REMARK 3 PLANARITY : 0.005 795 REMARK 3 DIHEDRAL : 17.187 2756 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FNJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-FEB-18. REMARK 100 THE DEPOSITION ID IS D_1200008526. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-NOV-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID30B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.708479 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS XDSAPP 2.0 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 210835 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.239 REMARK 200 RESOLUTION RANGE LOW (A) : 45.340 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.680 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.1400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : 6.43 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.140 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2VWU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 % PEG5000 MME, 0.15 M MGCL2, 15 % REMARK 280 GLYCEROL, 0.1 M TRIS PH 7.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.84500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 596 REMARK 465 MET A 597 REMARK 465 ASP A 598 REMARK 465 PRO A 599 REMARK 465 ASN A 600 REMARK 465 GLU A 601 REMARK 465 ALA A 602 REMARK 465 VAL A 603 REMARK 465 ARG A 604 REMARK 465 GLU A 605 REMARK 465 PHE A 606 REMARK 465 SER A 762 REMARK 465 ARG A 763 REMARK 465 PHE A 764 REMARK 465 LEU A 765 REMARK 465 GLU A 766 REMARK 465 GLU A 767 REMARK 465 ASN A 768 REMARK 465 SER A 769 REMARK 465 SER A 770 REMARK 465 ASP A 771 REMARK 465 PRO A 772 REMARK 465 THR A 773 REMARK 465 GLU A 774 REMARK 465 THR A 775 REMARK 465 SER A 776 REMARK 465 SER A 777 REMARK 465 LEU A 778 REMARK 465 GLY A 779 REMARK 465 GLY A 780 REMARK 465 LYS A 781 REMARK 465 ARG A 889 REMARK 465 GLU A 890 REMARK 465 ASN A 891 REMARK 465 GLY A 892 REMARK 465 GLY B 596 REMARK 465 MET B 597 REMARK 465 ASP B 598 REMARK 465 PRO B 599 REMARK 465 ASN B 600 REMARK 465 GLU B 601 REMARK 465 ALA B 602 REMARK 465 VAL B 603 REMARK 465 ARG B 604 REMARK 465 GLU B 605 REMARK 465 PHE B 606 REMARK 465 SER B 762 REMARK 465 ARG B 763 REMARK 465 PHE B 764 REMARK 465 LEU B 765 REMARK 465 GLU B 766 REMARK 465 GLU B 767 REMARK 465 ASN B 768 REMARK 465 SER B 769 REMARK 465 SER B 770 REMARK 465 ASP B 771 REMARK 465 PRO B 772 REMARK 465 THR B 773 REMARK 465 GLU B 774 REMARK 465 THR B 775 REMARK 465 SER B 776 REMARK 465 SER B 777 REMARK 465 LEU B 778 REMARK 465 GLY B 779 REMARK 465 GLY B 780 REMARK 465 LYS B 781 REMARK 465 ARG B 889 REMARK 465 GLU B 890 REMARK 465 ASN B 891 REMARK 465 GLY B 892 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 637 C - N - CA ANGL. DEV. = 11.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 619 138.81 -170.38 REMARK 500 ARG A 739 -17.64 80.96 REMARK 500 ARG A 739 -21.37 82.16 REMARK 500 PRO A 783 41.13 -76.90 REMARK 500 TRP A 822 -138.49 53.08 REMARK 500 ASN A 880 74.79 -118.42 REMARK 500 ARG B 739 -19.53 81.73 REMARK 500 ARG B 739 -20.17 82.13 REMARK 500 ASP B 740 44.73 -140.70 REMARK 500 PRO B 783 43.94 -68.28 REMARK 500 TRP B 822 -141.55 56.10 REMARK 500 TRP B 822 -137.84 56.10 REMARK 500 ASP B 823 30.26 -95.43 REMARK 500 ASN B 880 69.84 -119.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DWT A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DWT B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 1002 DBREF 6FNJ A 598 892 UNP P54760 EPHB4_HUMAN 598 892 DBREF 6FNJ B 598 892 UNP P54760 EPHB4_HUMAN 598 892 SEQADV 6FNJ GLY A 596 UNP P54760 EXPRESSION TAG SEQADV 6FNJ MET A 597 UNP P54760 EXPRESSION TAG SEQADV 6FNJ GLU A 774 UNP P54760 TYR 774 ENGINEERED MUTATION SEQADV 6FNJ VAL A 803 UNP P54760 ALA 803 ENGINEERED MUTATION SEQADV 6FNJ ILE A 870 UNP P54760 VAL 870 ENGINEERED MUTATION SEQADV 6FNJ GLY B 596 UNP P54760 EXPRESSION TAG SEQADV 6FNJ MET B 597 UNP P54760 EXPRESSION TAG SEQADV 6FNJ GLU B 774 UNP P54760 TYR 774 ENGINEERED MUTATION SEQADV 6FNJ VAL B 803 UNP P54760 ALA 803 ENGINEERED MUTATION SEQADV 6FNJ ILE B 870 UNP P54760 VAL 870 ENGINEERED MUTATION SEQRES 1 A 297 GLY MET ASP PRO ASN GLU ALA VAL ARG GLU PHE ALA LYS SEQRES 2 A 297 GLU ILE ASP VAL SER TYR VAL LYS ILE GLU GLU VAL ILE SEQRES 3 A 297 GLY ALA GLY GLU PHE GLY GLU VAL CYS ARG GLY ARG LEU SEQRES 4 A 297 LYS ALA PRO GLY LYS LYS GLU SER CYS VAL ALA ILE LYS SEQRES 5 A 297 THR LEU LYS GLY GLY TYR THR GLU ARG GLN ARG ARG GLU SEQRES 6 A 297 PHE LEU SER GLU ALA SER ILE MET GLY GLN PHE GLU HIS SEQRES 7 A 297 PRO ASN ILE ILE ARG LEU GLU GLY VAL VAL THR ASN SER SEQRES 8 A 297 MET PRO VAL MET ILE LEU THR GLU PHE MET GLU ASN GLY SEQRES 9 A 297 ALA LEU ASP SER PHE LEU ARG LEU ASN ASP GLY GLN PHE SEQRES 10 A 297 THR VAL ILE GLN LEU VAL GLY MET LEU ARG GLY ILE ALA SEQRES 11 A 297 SER GLY MET ARG TYR LEU ALA GLU MET SER TYR VAL HIS SEQRES 12 A 297 ARG ASP LEU ALA ALA ARG ASN ILE LEU VAL ASN SER ASN SEQRES 13 A 297 LEU VAL CYS LYS VAL SER ASP PHE GLY LEU SER ARG PHE SEQRES 14 A 297 LEU GLU GLU ASN SER SER ASP PRO THR GLU THR SER SER SEQRES 15 A 297 LEU GLY GLY LYS ILE PRO ILE ARG TRP THR ALA PRO GLU SEQRES 16 A 297 ALA ILE ALA PHE ARG LYS PHE THR SER ALA SER ASP VAL SEQRES 17 A 297 TRP SER TYR GLY ILE VAL MET TRP GLU VAL MET SER PHE SEQRES 18 A 297 GLY GLU ARG PRO TYR TRP ASP MET SER ASN GLN ASP VAL SEQRES 19 A 297 ILE ASN ALA ILE GLU GLN ASP TYR ARG LEU PRO PRO PRO SEQRES 20 A 297 PRO ASP CYS PRO THR SER LEU HIS GLN LEU MET LEU ASP SEQRES 21 A 297 CYS TRP GLN LYS ASP ARG ASN ALA ARG PRO ARG PHE PRO SEQRES 22 A 297 GLN ILE VAL SER ALA LEU ASP LYS MET ILE ARG ASN PRO SEQRES 23 A 297 ALA SER LEU LYS ILE VAL ALA ARG GLU ASN GLY SEQRES 1 B 297 GLY MET ASP PRO ASN GLU ALA VAL ARG GLU PHE ALA LYS SEQRES 2 B 297 GLU ILE ASP VAL SER TYR VAL LYS ILE GLU GLU VAL ILE SEQRES 3 B 297 GLY ALA GLY GLU PHE GLY GLU VAL CYS ARG GLY ARG LEU SEQRES 4 B 297 LYS ALA PRO GLY LYS LYS GLU SER CYS VAL ALA ILE LYS SEQRES 5 B 297 THR LEU LYS GLY GLY TYR THR GLU ARG GLN ARG ARG GLU SEQRES 6 B 297 PHE LEU SER GLU ALA SER ILE MET GLY GLN PHE GLU HIS SEQRES 7 B 297 PRO ASN ILE ILE ARG LEU GLU GLY VAL VAL THR ASN SER SEQRES 8 B 297 MET PRO VAL MET ILE LEU THR GLU PHE MET GLU ASN GLY SEQRES 9 B 297 ALA LEU ASP SER PHE LEU ARG LEU ASN ASP GLY GLN PHE SEQRES 10 B 297 THR VAL ILE GLN LEU VAL GLY MET LEU ARG GLY ILE ALA SEQRES 11 B 297 SER GLY MET ARG TYR LEU ALA GLU MET SER TYR VAL HIS SEQRES 12 B 297 ARG ASP LEU ALA ALA ARG ASN ILE LEU VAL ASN SER ASN SEQRES 13 B 297 LEU VAL CYS LYS VAL SER ASP PHE GLY LEU SER ARG PHE SEQRES 14 B 297 LEU GLU GLU ASN SER SER ASP PRO THR GLU THR SER SER SEQRES 15 B 297 LEU GLY GLY LYS ILE PRO ILE ARG TRP THR ALA PRO GLU SEQRES 16 B 297 ALA ILE ALA PHE ARG LYS PHE THR SER ALA SER ASP VAL SEQRES 17 B 297 TRP SER TYR GLY ILE VAL MET TRP GLU VAL MET SER PHE SEQRES 18 B 297 GLY GLU ARG PRO TYR TRP ASP MET SER ASN GLN ASP VAL SEQRES 19 B 297 ILE ASN ALA ILE GLU GLN ASP TYR ARG LEU PRO PRO PRO SEQRES 20 B 297 PRO ASP CYS PRO THR SER LEU HIS GLN LEU MET LEU ASP SEQRES 21 B 297 CYS TRP GLN LYS ASP ARG ASN ALA ARG PRO ARG PHE PRO SEQRES 22 B 297 GLN ILE VAL SER ALA LEU ASP LYS MET ILE ARG ASN PRO SEQRES 23 B 297 ALA SER LEU LYS ILE VAL ALA ARG GLU ASN GLY HET DWT A1001 37 HET DWT B1001 37 HET EDO B1002 4 HETNAM DWT 4-METHYL-3-[(2-METHYL-6-PYRIDIN-3-YL-PYRAZOLO[3,4- HETNAM 2 DWT D]PYRIMIDIN-4-YL)AMINO]-~{N}-[3-(TRIFLUOROMETHYL) HETNAM 3 DWT PHENYL]BENZAMIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 DWT 2(C26 H20 F3 N7 O) FORMUL 5 EDO C2 H6 O2 FORMUL 6 HOH *646(H2 O) HELIX 1 AA1 ASP A 611 SER A 613 5 3 HELIX 2 AA2 THR A 654 GLY A 669 1 16 HELIX 3 AA3 ALA A 700 ASN A 708 1 9 HELIX 4 AA4 THR A 713 MET A 734 1 22 HELIX 5 AA5 ALA A 742 ARG A 744 5 3 HELIX 6 AA6 PRO A 783 THR A 787 5 5 HELIX 7 AA7 ALA A 788 ARG A 795 1 8 HELIX 8 AA8 THR A 798 SER A 815 1 18 HELIX 9 AA9 SER A 825 GLN A 835 1 11 HELIX 10 AB1 PRO A 846 TRP A 857 1 12 HELIX 11 AB2 ASP A 860 ARG A 864 5 5 HELIX 12 AB3 ARG A 866 ASN A 880 1 15 HELIX 13 AB4 PRO A 881 LYS A 885 5 5 HELIX 14 AB5 ASP B 611 SER B 613 5 3 HELIX 15 AB6 THR B 654 GLN B 670 1 17 HELIX 16 AB7 ALA B 700 ASN B 708 1 9 HELIX 17 AB8 THR B 713 MET B 734 1 22 HELIX 18 AB9 ALA B 742 ARG B 744 5 3 HELIX 19 AC1 PRO B 783 THR B 787 5 5 HELIX 20 AC2 ALA B 788 ARG B 795 1 8 HELIX 21 AC3 THR B 798 SER B 815 1 18 HELIX 22 AC4 SER B 825 GLN B 835 1 11 HELIX 23 AC5 PRO B 846 TRP B 857 1 12 HELIX 24 AC6 ASP B 860 ARG B 864 5 5 HELIX 25 AC7 ARG B 866 ASN B 880 1 15 HELIX 26 AC8 PRO B 881 ILE B 886 5 6 SHEET 1 AA1 5 VAL A 615 ALA A 623 0 SHEET 2 AA1 5 GLU A 628 LEU A 634 -1 O ARG A 631 N GLU A 619 SHEET 3 AA1 5 SER A 642 LEU A 649 -1 O ILE A 646 N CYS A 630 SHEET 4 AA1 5 VAL A 689 GLU A 694 -1 O ILE A 691 N LYS A 647 SHEET 5 AA1 5 LEU A 679 VAL A 683 -1 N GLU A 680 O LEU A 692 SHEET 1 AA2 2 ILE A 746 VAL A 748 0 SHEET 2 AA2 2 CYS A 754 VAL A 756 -1 O LYS A 755 N LEU A 747 SHEET 1 AA3 5 VAL B 615 ALA B 623 0 SHEET 2 AA3 5 GLU B 628 LEU B 634 -1 O VAL B 629 N ILE B 621 SHEET 3 AA3 5 SER B 642 LEU B 649 -1 O ILE B 646 N CYS B 630 SHEET 4 AA3 5 VAL B 689 GLU B 694 -1 O VAL B 689 N LEU B 649 SHEET 5 AA3 5 LEU B 679 VAL B 683 -1 N GLU B 680 O LEU B 692 SHEET 1 AA4 2 ILE B 746 VAL B 748 0 SHEET 2 AA4 2 CYS B 754 VAL B 756 -1 O LYS B 755 N LEU B 747 CISPEP 1 MET A 687 PRO A 688 0 1.90 CISPEP 2 MET B 687 PRO B 688 0 2.02 SITE 1 AC1 20 VAL A 629 ALA A 645 LYS A 647 GLU A 664 SITE 2 AC1 20 MET A 668 PHE A 671 ILE A 676 ILE A 677 SITE 3 AC1 20 THR A 693 PHE A 695 MET A 696 TYR A 736 SITE 4 AC1 20 HIS A 738 LEU A 747 VAL A 756 SER A 757 SITE 5 AC1 20 ASP A 758 PHE A 759 HOH A1217 HOH A1246 SITE 1 AC2 20 VAL B 629 ALA B 645 LYS B 647 GLU B 664 SITE 2 AC2 20 MET B 668 PHE B 671 ILE B 676 ILE B 677 SITE 3 AC2 20 THR B 693 PHE B 695 MET B 696 TYR B 736 SITE 4 AC2 20 HIS B 738 LEU B 747 VAL B 756 SER B 757 SITE 5 AC2 20 ASP B 758 PHE B 759 HOH B1237 HOH B1285 SITE 1 AC3 7 TYR B 736 VAL B 737 HIS B 738 ARG B 739 SITE 2 AC3 7 HOH B1103 HOH B1209 HOH B1236 CRYST1 54.820 87.690 81.742 90.00 104.95 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018242 0.000000 0.004871 0.00000 SCALE2 0.000000 0.011404 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012662 0.00000